BioStorage Technologies, through its partnership with BGI-Shenzhen, will provide technical consulting services to the China National Genebank-(CNGB) for the development of China’s first national biobank.

The CNGB was established by BGI-Shenzhen and is dedicated to developing a biobank consortium across China and an expanding worldwide network to better support global data sharing and exchange of biobank best practices, including biobank construction, genomics research and data acquisition. The CNGB aims to store 30 million biological, animal and agricultural samples collected from research institutions, universities and hospitals in China.

Physical samples stored within the CNGB biobank will be used to serve scientific research and potential industrialization, such as translational medicine, breeding, and new energy exploration. BioStorage has capabilities in comprehensive sample management including the development of best practices for biorepository operations and global technology platforms.

“BioStorage Technologies is honored to be selected as a partner on one of the largest genomic biobanks in the world,” said Greg Swanberg, chief executive officer, BioStorage Technologies. “The combination of our proprietary technological platforms with BGI’s scientific and data capabilities provides the CNGB with the global capabilities required to be a vital asset to the research industry.”

“The CNGB is dedicated to supporting the growth of the genomics industry within China by developing the world’s largest collection of biological samples to advance new and innovative research,” said Dr. Yong Zhang, director of CNGB. “As the global leader in sample management, BioStorage Technologies was selected as our strategic partner based on their ability to provide technical sample management consulting, process leadership and innovative technology solutions.”